This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

R. D. TAYLOR, M.D.; HARRIET P. DUSTAN, M.D.; A. C. CORCORAN, M.D.; IRVINE H. PAGE, M.D.

AMA Arch Intern Med. 1952;90(6):734-749.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

DEMONSTRATION of a humorally mediated pressor mechanism of centralnervous origin¹ prompted the suggestion that this system might sometimes participate in the genesis of essential hypertension. Since the pressor effect was suppressed by "apresoline" (1-hydrazinophthalazine, Ciba), it was considered possible that patients in whom the mechanism was operative would respond favorably and relatively specifically to treatment with this drug. It was recognized that the drug has properties which might tend to decrease arterial pressure by other means than inhibition of cerebral pressor activity.

With these considerations in mind, a survey was initiated of the therapeutic effects of "apresoline" when administered as the sole antipressor agent to patients suffering from a wide spectrum of hypertensive disease.

METHOD OF STUDY

Ninety-seven patients were treated with "apresoline" for at least 3 months and usually for 12 months or more. Of these, 58 were hospitalized for close observation and at least preliminary treatment; as . . . [Full Text PDF of this Article]

Author Affiliations
CLEVELAND

From the Research Division of the Cleveland Clinic Foundation and the Frank E. Bunts Educational Institute.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?